3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Lymphoma, Follicular
5
Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Lymphoma, Large B-Cell, Diffuse
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Diseases
1
Graft vs Host Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Bronchiolitis Obliterans Syndrome
1
Anemia
1
Interventions
enzalutamide
2
apalutamide
2
Pluvicto
2
Leuprolide
2
Androgen Antagonists
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
luprolide acetate gel depot
1
larotrectinib
1
ipatasertib
1
gallium 68 PSMA-11
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Prostatic Neoplasms
×
Rituximab
×
Clear all
No trials found.